Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001878894-21-000003

Options or other derivatives

  • Chief Executive Officer acquired 78,116 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

COLA MICHAEL F · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-10-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +78,116 78,116 D
Loading xslF345X03/edgar.xml…